Your browser doesn't support javascript.
loading
Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.
Denney, William S; Sonnenberg, Gabriele E; Carvajal-Gonzalez, Santos; Tuthill, Theresa; Jackson, V Margaret.
Afiliação
  • Denney WS; Biotherapeutics Clinical Pharmacology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, 02139, USA.
  • Sonnenberg GE; Cardiovascular, Metabolic, and Endocrine Diseases Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, 02139, USA.
  • Carvajal-Gonzalez S; Cardiovascular, Metabolic, and Endocrine Diseases Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, 02139, USA.
  • Tuthill T; Cardiovascular, Metabolic, and Endocrine Diseases Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, 02139, USA.
  • Jackson VM; Cardiovascular, Metabolic, and Endocrine Diseases Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, 02139, USA.
Br J Clin Pharmacol ; 83(2): 326-338, 2017 02.
Article em En | MEDLINE | ID: mdl-27621150

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Espiro / Azetidinas / Receptores de Grelina / Agonismo Inverso de Drogas Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Espiro / Azetidinas / Receptores de Grelina / Agonismo Inverso de Drogas Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article